grantDOI: https://doi.org/10.54464/pc.gr.160968 studyName: Combining the inhibition of the Ras-MAPK pathway and the activation of the cAMP-PKA pathway as a therapeutic strategy for cutaneous neurofibromas dataStatus: Under Embargo initiative: Biology and Therapeutic Development for Cutaneous Neurofibromas studyLeads: Eduard Serra studyStatus: Active diseaseFocus: Neurofibromatosis type 1 grantEndDate: 1774915200000 institutions: Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP) fundingAgency: NTAP embargoEndDate: 1822262400000 grantStartDate: 1680307200000 relatedStudies: syn4939872 syn11374333 syn51356860 syn11374354 studyFileviewId: syn51658222 syn51658172 syn61251558 syn51658173 syn51658222 syn51658174
Drop files to upload
Combining the inhibition of the Ras-MAPK pathway and the activation of the cAMP-PKA pathway as a therapeutic strategy for cutaneous neurofibromas page is loading…